The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Anthony Gershlick
Showing 1-20 of 24 articles
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial
Banning A,
Adriaenssens T,
Berry C,
Bogaerts K,
Erglis A,
Distelmaier K,
Guagliumi G,
Haine S,
Kastrati A,
Massberg S,
Orban M,
Myrmel T,
Vuylsteke A,
Alfonso F,
Van de Werf F,
Verheugt F,
Flather M,
Sabaté M,
Vrints C,
Gershlick A
February 5, 2021 | 10.4244/EIJ-D-20-01076
Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial
Kandzari D,
Gershlick A,
Serruys P,
Leon M,
Morice M,
Simonton C,
Lembo N,
Mansour S,
Sabaté M,
Sabik J,
Kappetein A,
Dressler O,
Stone G
December 18, 2020 | 10.4244/EIJ-D-19-00686
Complete revascularisation in the STEMI patient: is it worth the effort?
Gershlick A,
Banning A
June 25, 2020 | 10.4244/EIJV16I3A34
Spotlight on N-STEMI ACS: getting the right patients the right treatment, and at the right time
Kite T,
Gersh B,
Gershlick A
December 20, 2019 | 10.4244/EIJV15I12A196
Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club
Galassi A,
Werner G,
Boukhris M,
Azzalini L,
Mashayekhi K,
Carlino M,
Avran A,
Konstantinidis N,
Grancini L,
Bryniarski L,
Garbo R,
Bozinovic N,
Gershlick A,
Rathore S,
Di Mario C,
Louvard Y,
Reifart N,
Sianos G
June 20, 2019 | 10.4244/EIJ-D-18-00826
Invasive cardiovascular needs in South Africa: a view from afar up close
Holmes D,
King S,
Gershlick A,
Marco J,
Koolen J,
Pichard A,
Bassand J-P,
Kettles D,
Wijns W,
Ntsekhe M
October 19, 2018 | 10.4244/EIJV14I8A153
STEMI – are we there yet?
Gershlick A
March 20, 2018 | 10.4244/EIJV13I16A304
Contemporary considerations in left main stem treatment
Gershlick A,
Banning A
November 20, 2017 | 10.4244/EIJV13I10A179
Will this trial change my practice? The Dual Antiplatelet Therapy (DAPT) study – 12 or 30 months of dual antiplatelet therapy after drug-eluting stents
Grundeken M.J,
Lansky A,
Tanguay J,
Gershlick A,
Baumbach A,
Cuisset T
July 20, 2015 | 10.4244/EIJV11I3A71
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI
Brener S,
Dambrink J-H,
Maehara A,
Chowdhary S,
Gershlick A,
Généreux P,
Koolen J,
Mehran R,
Fahy M,
Gibson CM,
Stone G
February 20, 2014 | 10.4244/EIJV9I10A201
Highlights from The Experts “Live”, 4th annual congress of the Euro CTO Club, London 2012
Di Mario C,
Hildick-Smith D,
Gershlick A,
Ghione M,
Agudo P,
Alahmar A,
Galassi A,
Werner G
April 19, 2013 | 10.4244/EIJV8I12A208
Hybrid revascularisation in multivessel coronary artery disease: could a combination of CABG and PCI be the best option in selected patients?
Wrigley B,
Dubey G,
Spyt T,
Gershlick A
March 22, 2013 | 10.4244/EIJV8I11A202
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design
Kelly D,
McCann G,
Blackman D,
Curzen N,
Dalby M,
Greenwood J,
Fairbrother K,
Shipley L,
Kelion A,
Heatherington S,
Khan J,
Nazir S,
Alahmar A,
Flather M,
Swanton H,
Schofield P,
Gunning M,
Hall R,
Gershlick A
February 22, 2013 | 10.4244/EIJV8I10A183
Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study
Hamon M,
Rao S,
Steg G,
Valgimigli M,
Verheugt F,
Marso S,
Gershlick A,
Wang Y,
Deliargyris E
August 24, 2012 | 10.4244/EIJV8I4A76
Recanalisation of Chronic Total coronary Occlusions: 2012 consensus document from the EuroCTO club
Sianos G,
Werner G,
Galassi A,
Papafaklis M,
Escaned J,
Hildick-Smith D,
Christiansen E,
Gershlick A,
Carlino M,
Karlas A,
Konstantinidis N,
Tomasello S,
Di Mario C,
Reifart N
May 15, 2012 | 10.4244/EIJV8I1A21
Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base
Maznyczka A,
Myat A,
Gershlick A
January 20, 2012 | 10.4244/EIJV7I9A175
In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry
Galassi A,
Tomasello S,
Reifart N,
Werner G,
Sianos G,
Bonnier H,
Sievert H,
Ehladad S,
Bufe A,
Schofer J,
Gershlick A,
Hildick-Smith D,
Escaned J,
Erglis A,
Sheiban I,
Thuesen L,
Serra A,
Christiansen E,
Buettner A,
Costanzo L,
Barrano G,
Di Mario C
August 30, 2011 | 10.4244/EIJV7I4A77
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial
Duckers H,
Houtgraaf J,
Hehrlein C,
Schofer J,
Waltenberger J,
Gershlick A,
Bartunek J,
Nienaber C,
Naber C,
Macaya C,
Peters N,
Smits P,
Siminiak T,
van Mieghem W,
Legrand V,
Serruys P
February 21, 2011
Cost-effectiveness of the Endeavor stent in de novo native coronary artery lesions updated with contemporary data
Remak E,
Manson S,
Hutton J,
Brasseur P,
Olivier E,
Gershlick A
February 25, 2010
Health economics: drug-eluting stents – are they worth the money?
Gershlick A,
Fearn S
August 20, 2008
1
2
Latest news
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
#EIJonAir - Renal denervation in the management of hypertension
March 22, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke